PFIZER INC PFE
NYSE · XNYS · stock · Pharmaceutical Preparations · website · IPO 1944-01-17
PFIZER INC statistics & valuation
Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else is from filings.
Key ratios (by fiscal year)
| Ratio | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Net margin | 12.4% | 12.6% | 3.6% | 31.0% | 27.0% |
| FCF margin | 14.5% | 15.5% | 8.0% | 25.7% | 37.2% |
| Return on assets | 3.7% | 3.8% | 0.9% | 15.9% | 12.1% |
| Return on equity | 9.0% | 9.1% | 2.4% | 32.7% | 28.4% |
| Debt / equity | 0.71× | 0.65× | 0.69× | 0.34× | 0.47× |
| Current ratio | 1.16 | 1.17 | 0.91 | 1.22 | 1.40 |
| Revenue growth | -1.6% | 6.8% | -41.1% | 24.5% | 95.2% |
Source: SEC EDGAR filings · CIK 0000078003 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.